Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Ocul Immunol Inflamm
; 29(6): 1212-1215, 2021 Aug 18.
Article
in English
| MEDLINE | ID: covidwho-1402198
ABSTRACT
A 54-year-old Chinese male with no previous ocular history presented to the ophthalmology department for the bilateral acute painless blurring of vision after receiving the 1st dose of COVID-19 mRNA vaccine (PFIZER-BioNTech/COMIRNATY). Clinical examination and imaging tests were consistent with Vogt-Koyanagi-Hara disease. The patient responded well with a high dose of intravenous methylprednisolone followed by a tapering dose of oral prednisolone.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Uveomeningoencephalitic Syndrome
/
Vaccination
/
SARS-CoV-2
/
COVID-19
/
BNT162 Vaccine
Type of study:
Case report
/
Diagnostic study
/
Prognostic study
Topics:
Vaccines
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Ocul Immunol Inflamm
Journal subject:
Allergy and Immunology
/
Ophthalmology
Year:
2021
Document Type:
Article
Affiliation country:
09273948.2021.1974492
Similar
MEDLINE
...
LILACS
LIS